Urinall

Urinall is an Israeli medical technology company focused on developing innovative solutions for non-invasive urological diagnostics. The company's core technology is a specialized urine collection device designed to capture the "first-void" or "first-catch" urine, which contains the highest concentration of biomarkers for prostate and bladder cancers. This approach significantly enhances the sensitivity of liquid biopsies compared to traditional mid-stream collection methods. By enabling more accurate and user-friendly sampling, Urinall facilitates early disease detection and improved patient monitoring. The company's solution is designed for both clinical and home-based settings, aiming to reduce the need for invasive}